baber/WOPTO huggingface dataset:
Patent CA-2668461-A1 (CA)
Title: Handheld electronic device having multiple-axis input device and selectable input mode indicator, and associated method
Inventor: SCOTT SHERRYL LEE LORRAINE
IPC: G06F3/041
Filed: 2007-11-09
Abstract: A method of enabling input into a handheld electronic device comprises outputting an input mode indicator comprising a representation of an operative input method language as a first characteristic of a current input mode and further comprising a representation of a second characteristic of the current input mode, detecting an input from a multiple-axis input device as being a selection input with respect to the input mode indicator and, responsive thereto, enabling the current input mode to be changed.
Patent CA-2668738-A1 (CA)
Inventor: SATO YOSHIYUKI
IPC: C07D471/04
Filed: 2007-12-20
Abstract: Disclosed is a compound represented by the general formula (I) below, or a pharmaceutically acceptable salt or ester thereof. (In the formula, R1 and R2 may be the same or different and represent a hydrogen atom, a lower alkyl group, a cycloalkyl group or the like; R3 and R4 may be the same or different and represent a hydrogen atom, a lower alkyl group, an NRaRb, a phenyl group, a lower alkyl group substituted with a phenyl group, a 4- or 7-membered aliphatic heterocyclic group, a lower alkyl group substituted with a 4- or 7-membered aliphatic heterocyclic group, a 5- or 6-membered aromatic heterocyclic group, a lower alkyl group substituted with a 5- or 6-membered aromatic heterocyclic group or the like; and R5 represents a hydrogen atom, a cyano group, a halogen atom or a lower alkyl group.)
Patent CA-2670881-A1 (CA)
Inventor: SANTOS MARCELO AUGUSTO
IPC: B01J8/02
Filed: 2006-12-08
Abstract: A method and system for the enzymatic treatment of a lipid containing feedstock comprises contacting the feedstock with a processing aid, then causing the feedstock to pass at a substantially constant flow rate through a treatment system comprising a plurality of enzyme-containing fixed bed reactors connected to one another in series. The fixed bed reactors can be individually serviceable, the flow rate of the feedstock remaining substantially constant through the system when one of the fixed bed reactors is taken off line for servicing. In the most preferred embodiment, the processing aid is a substantially moisture-free silica. The processing aid can be placed in one or more of the fixed bed reactors, disposed above the enzyme in the reactor, or it can be in a pre-treatment system which can comprise one or more reactors.
Patent CA-2672103-A1 (CA)
Inventor: HASSAN AMER A
IPC: H04L27/26
Filed: 2007-11-27
Abstract: A computing device operating according to a frequency division multiplexed protocol in which communication occurs over a signal formed from a plurality of sub-channels selected from anywhere in a frequency spectrum. A computing device may select sub-channels cognitively by using information about sub-channels previously deemed suitable or unsuitable by that computing device or other computing devices. A described technique for determining sub-channel suitability includes analyzing radio frequency energy in the sub-channel to detect signals generated by another computing device or high noise levels. Information may also be used to cognitively select sub-channels to be analyzed, such as by first selecting for analysis previously-used sub-channels.
Patent CA-2672333-A1 (CA)
Title: Electrical distribution panel including first non-critical load bus and second critical load bus
Inventor: REMMERT SCOT E
IPC: H02J3/06
Filed: 2009-07-14
Abstract: A load center includes an enclosure, a first power input, a second power input, a first circuit breaker having a line terminal electrically connected to the first power input and a load terminal, a first bus electrically connected to the load terminal, a number of independent second circuit breakers powered from the first bus, a second bus, a number of independent third circuit breakers powered from the second bus, and a transfer switch having a first input electrically connected to the first bus, a second input electrically connected to the second power input, and an output electrically connected to the second bus. The transfer switch selectively electrically connects one of its first and second inputs to its output. The first bus and the second circuit breakers power only a number of non-critical loads. The second bus and the third circuit breakers power only a number of critical loads.
Patent CA-2672503-A1 (CA)
Title: Substituted aminofuranones and their use
Inventor: GRESCHAT SUSANNE
IPC: A61K31/438
Filed: 2007-12-08
Abstract: The present invention relates to new substituted aminofuranones, to processes for preparing them, to their use for the treatment and/or prophylaxis of diseases, and also to their use for the production of pharmaceuticals for the treatment and/or prophylaxis of diseases, more particularly of retroviral disorders, in humans and/or animals.
Patent CA-2672722-A1 (CA)
Title: Methods of preparing substituted tetracyclines with transition metal-based chemistries
Inventor: NELSON MARK L
IPC: C07D213/56
Filed: 2000-09-13
Abstract: The present invention relates to novel chemistries which allow for heretofore unobtainable substituted tetracycline compounds which exhibit significant antibacterial activity. The methods disclosed herein utilize reactive tetracycline-based precursor compounds, reactive organic substituent precursors and transition metal catalysts under conditions such that a tetracycline compound substituted with the desired organic substituent is formed. In one embodiment of the invention, a substituted tetracycline compound may be prepared by combining a reactive tetracycline-based precursor compound such as an arene tetracycline diazonium salt, and a reactive organic substituent precursor, e.g., alkenes, substituted alkenes, vinyl monomers, aromatics and heteroaromatics, in the presence of a transition metal catalyst, such as palladium chloride, under conditions such that a tetracycline compound substituted with the organic substituent is formed. Such compounds may optionally act as intermediates for making other compounds, e.g., hydrogenation of unsaturated groups on the substituent.
Patent CA-2672845-A1 (CA)
Title: Fuel composition sensing systems and methods using emf wave propagation
Inventor: MCCALL ALAN
IPC: F02D19/08
Filed: 2007-12-18
Abstract: A flex fuel sensor is deployed in conjunction with the fuel transfer line (e.g. around a plastic fuel line) or at the bottom/side of a fuel tank. An RF signal of a constant frequency may be generated across a resonant circuit, which comprises of an inductor and a PCB trace capacitor, capacitor plates, semi cylindrical capacitor plates, or the like. Electromagnetic radiation is propagated into the passing fuel in the transfer pipe. The conductivity and dielectric properties of the fuel change the capacitance of the trace capacitor/capacitor plates. These changes are proportional to ethanol/alcohol content of the fuel and are preferably detected by a microcontroller, or the like, and then transmitted to a flex fuel vehicle Engine Management System.
Patent CA-2674369-A1 (CA)
Title: Fused substituted aminopyrrolidine derivative
Inventor: NAGAMOCHI MASATOSHI
IPC: C07D401/04
Filed: 2007-12-28
Abstract: A quinolone synthetic antibacterial agent having excellent properties as a medicine is provided, which has strong antibacterial activity not only to Gram-negative bacteria but also to Gram-positive cocci that have low sensitivity to quinolone antibacterial agents, and which exhibits high safety and excellent pharmacokinetics. A compound represented by the formula (I) or a salt thereof, or a hydrate thereof. Specifically, a quinolone derivative of the formula (I) wherein substituents R6 and R7 taken together with the carbon atoms to which they are bonded form a cyclic structure which may contain an oxygen atom as a ring constituent atom, the cyclic structure forming a 5-4, 5-5, or 5-6 fused bicyclic pyrrolidinyl substituent, the substituent being bonded to a quinolone mother skeleton Q containing a pyridobenzoxazine structure.
Patent CA-2675931-A1 (CA)
Inventor: FORMANEK JOSEPH A
IPC: A23L11/00
Filed: 2008-02-12
Abstract: Unique adherent coated roasted and unroasted bean, pea and nut substrates carrying finely divided ingredients, the adherent coating including an alginate salt, a source of calcium ions and carrageenan, and the method of making such unique coated beans, peas and nuts.
Patent CA-2675987-A1 (CA)
Title: Amorphous fe100-a-bpamb alloy foil and method for its preparation
Inventor: HOULACHI GEORGES
IPC: C25C1/24
Filed: 2008-02-01
Abstract: Amorphous Fe100-a-bPaMb foil, preferably in the form of a free-standing foil, process for its production by electrodeposition or electroforming of an aqueous plating solution, and its uses as a constitutive element of a transformer, generator, motor, pulse applications and magnetic shieldings. "a" is a real number ranging from 13 to 24, b is a real number ranging from 0 to 4, and M is at least one transition element other than Fe. The amorphous Fe100-a-bPaMb foil has the properties of being amorphous as established by the X-ray diffraction method, an average thickness greater than 20 micrometers, a tensile strength in the range of 200-1100 MPa, an electrical resistivity of over 120 µ.OMEGA.cm, and at least one of a high saturation induction (Bs) greater than 1.4 T, a coercive field (Hc) of less than 40 A/m, a loss (W60), at power frequencies (60 Hz), and for a peak induction of at least 1.35 T, of less than 0.65 W/kg, and a relative magnetic permeability (B/µ0H) greater than 10000, for low values of µoH.
Patent CA-2677172-A1 (CA)
Inventor: BOYUM HAGEDORN BRIAN
IPC: A61M39/02
Filed: 2008-02-01
Abstract: A gateway device for the delivery of a drug, said device comprising a cannula (40) for delivery of said drug, a housing (10) having a base (20) adapted for being placed against the skin of a patient, and a receiving area (30) for receiving a coupling portion (2) of a drug supply device (4) for supplying said drug to said gateway device, said receiving area (30) including a hollow tubular coupling (50) having a free end (52) and being for engaging said coupling portion, said hollow tubular coupling (50) being arranged for delivery of said drug to said patient via said cannula (40). The cannula (40) is secured to said housing (10) to allow said cannula (40) to project from said housing (10), wherein a hollow tubular member with a first end portion and a second end portion defines said cannula and said tubular coupling.
Patent CA-2677862-A1 (CA)
Title: Fractionation of a lignocellulosic material
Inventor: EDYE LESLIE ALAN
IPC: C13B10/14
Filed: 2008-02-07
Abstract: A method for fractionating a lignocellulosic material, the method comprising; contacting (2) the lignocellulosic material with an ionic liquid (3) and dissolving the lignocellulosic material therein, providing a second liquid (7) which is immiscible with the ionic liquid and is also a non-solvent for cellulose, adding the second liquid to the ionic liquid so as to form a biphasic system (6) which comprises an ionic liquid phase essentially free of lignocellulose and a second liquid phase comprising lignin in solution and cellulose as a precipitate, separating the two phases and recovering (8) the precipitated cellulose from the separated second liquid phase.
Patent CA-2678478-A1 (CA)
Inventor: DUPUIS MATTHIEU JACQUES
IPC: B65D17/50
Filed: 2008-02-22
Abstract: The present invention relates to a metal container or component part (1) of a metal container (e.g. a can end or sidewall of a can body), having an aperture (5) defined by a cut edge (6) about the periphery of the aperture, with a cover element (7) sealed to the outward-facing surface of the can end so as to extend over and cover the aperture. A film of lacquer (4) is directly applied (without the presence of an intermediate primer layer) to the inward-facing of the container/component part so as to coat the entirety of the cut edge and all or part of the inward-facing surfaces of both the can end and that part of the cover element located radially inward of the cut edge, thereby inhibiting corrosion of the cut edge. The invention is particularly suitable for can ends. The invention also relates to a method of making a can end to the invention.
Patent CA-2678524-A1 (CA)
Inventor: KANG TONG HO
IPC: A61P3/10
Filed: 2006-12-12
Abstract: The present invention relates to a composition comprising shikonin compounds, especially, isobutyryl shikonin, .beta.,.beta.-dimethylacryl shikonin, isovaleryl shikonin, and .alpha.-methyl-n-butyryl shikonin as an active ingredient for the prevention and treatment of diabetes mellitus and the use thereof. The composition of the present invention showed stimulating effect on the release of insulin in the beta cell of the pancreas due to inhibitory effect on K ATP ion channel of beta cell in pancreas together with promoting effect on the increase of calcium concentration. Therefore, it can be used as the therapeutics, health functional food or food additive for treating and preventing diabetes mellitus.
Patent CA-2678912-A1 (CA)
Title: System and method for the continuous manufacture of long-length products or the like
Inventor: GARNEAU GLEN
IPC: B29C70/30
Filed: 2009-09-17
Abstract: This application relates to apparatus and processes for the wrapping or winding of continuous products, such as hose, cable, wire and composite pipe. The methods and apparatus allow for the continuous wrapping or winding of such products without stopping or slowing the production line for re-loading spools or bobbins of winding/wrapping material. The application also relates to an automatic loading system for loading and unloading the spools or bobbins or winding/wrapping material.
Patent CA-2685921-A1 (CA)
Inventor: GUPTA BHUPENDRA KUMAR
IPC: B23P6/00
Filed: 2009-11-12
Abstract: A method is provided for repairing a metallic turbine component which includes a thermal barrier coating system including a metallic bond coat (22) and a ceramic top coat (24). The method includes: (a) removing the top coat (24) using a mechanical process; (b) partially stripping the metallic bond coat (22) from the component, such that substantially no material of the component is removed; (c) repairing at least one defect in the turbine component; (d) applying a new metallic bond coat (26', 28') to the turbine component; and (e) applying a new ceramic top coat (24) over the metallic bond coat (26', 28').
Patent CA-2686908-A1 (CA)
Title: Rna antagonist compounds for the modulation of her3
Inventor: HEDTJAERN MAJ
IPC: A61K31/7088
Filed: 2008-05-09
Abstract: The invention relates to oligomeric compounds (oligomers), which target HER3 mRNA in a cell, leading to reduced expression of HER3 and/or HER2 and/or EGFR. Reduction of HER3 and/or HER2 and/or EGFR expression is beneficial for a range of medical disorders, such as hyperproliferative diseases, including cancer. The invention provides therapeu tic compositions comprising oligomers and methods for modulating the expression of HER3 and/or HER2 and/or EGFR using said oligomers, including methods of treatment.
Patent CA-2690739-A1 (CA)
Title: Echangeur de chaleur pour chaudiere
Inventor: MORINI MARIO
IPC: F28F13/06
Filed: 2008-06-12
Abstract: La présente invention concerne un échangeur de chaleur pour chaudière, comprenant, au sein d'une structure monolithique, au moins une paire (2, 3; 4, 5; 6, 7) de collecteurs mutuellement opposés connectés par des broches perforées (8, 9; 10, 11; 12, 13) insérées dans une partie d'espace qui est délimitée par la structure et est conçue pour véhiculer les produits de combustion, les collecteurs étant conçus pour assurer la circulation du fluide devant être chauffé entre un raccord d'entrée et un raccord de sortie.
Patent CA-2690777-A1 (CA)
Inventor: LARSSON THOMAS
IPC: F16L19/00
Filed: 2010-01-22
Abstract: A swivel joint comprises a pipe part and a swivel nut (2). The pipe part has a first end (4a) and a second end (4b) and the swivel nut (2) has a first end (11a) and a second end (11b). The swivel nut (2) is positioned on the pipe part such that the first end (11a) of the swivel nut (2) forms a swivel connection with the first end (4a) of the pipe part. The swivel nut (2) and the pipe part comprise shoulders (10, 17) against each other for preventing separation of the swivel nut (2) from the pipe part. The swivel nut (2) is made such that the swivel nut (2) and the pipe part are connected together by pushing the first end (11a) of the swivel nut (2) towards the first end (4a) of the pipe part whereby the swivel nut (2) and the pipe part are connected by a snap joint.
Patent CA-2690956-A1 (CA)
Inventor: HABBOUSHE JOSEPH PETER
IPC: A01N37/36
Filed: 2008-07-01
Abstract: A pharmaceutical composition in the form of a combination tablet is described.  The tablet has a rapidly absorbed component that enters the circulation by traversing the buccal mucosa, and a more slowly absorbed component that is swallowed. The therapeutic agent in the swallowed portion is absorbed across the gastric mucosa. The rapid and slow components may have identical or different therapeutic agents depending on the application to a specific medical condition One embodiment of the combination tablet includes a prostaglandin inhibitor in the rapidly absorbed component in order to mitigate the side effects of immediate release niacin that is in the slow absorbing component. Such combination compositions will increase patient compliance by reducing the number of tablets that a patient would need to take on a daily basis.
Patent CA-2691069-A1 (CA)
Inventor: KRULL MATTHIAS
IPC: C10L1/197
Filed: 2008-06-17
Abstract: The invention relates to the use of at least one oil-soluble compound B) which acts as a nucleating agent for paraffin crystallization and which is selected from ethylene copolymers and 2 to 10.5 mole-% of at least one ethylenically unsaturated carbonic ester for improving the response of cold flow improvers for mineral oils C), which are different from B), in middle distillates that contain at least one ashless, nitrogenous detergent additive A), which is an oil-soluble, amphiphilic compound that comprises at least one alkyl or alkenyl group bound to a polar group, said alkyl or alkenyl group having 10 to 500 C atoms and the polar group having 2 or more nitrogen atoms.
Patent CA-2695457-A1 (CA)
Inventor: PACIONE JOSEPH ROCCO
IPC: B31D5/04
Filed: 2007-08-03
Abstract: A method for installing a first surface covering element onto a surface is provided. The element has one half of a hook and loop attachment system, and the surface has the other of the hook and loop attachment system. The method may include the steps of: (i) placing the first element onto the surface so that at least some of the respective hooks and loops of the first element and surface engage; and (ii) applying a force to the first element to encourage tensioning in the loops; and (iii) securing the first element into place.
Patent CA-2695951-A1 (CA)
Inventor: FOGHER CORRADO
IPC: C07K14/435
Filed: 2006-12-19
Abstract: The present invention encompasses a method for the production of Apolipopro-teins in dimeric and/or oligomeric forms (comprising three or more units) of muteins of the human ApoA-1 protein in plant seeds, novel variants of these proteins having an increased stability and capacity to transport cholesterol compared to the native ApoA-1 protein, expression systems for the production thereof, plants transformed capable of producing said proteins in seeds in dimeric and/or oligomeric forms, and nutraceutical derivatives of these plants.
Patent CA-2695974-A1 (CA)
Inventor: AMBROSIO LUIGI
IPC: A23L29/262
Filed: 2008-08-08
Abstract: The invention relates to a method for the preparation of a polymer hydrogel, comprising cross-linking a precursor comprising a hydrophilic polymer optionally in combination with a second hydrophilic polymer, using a polycarboxylic acid as the cross-linking agent. The invention further concerns the polymer hydrogel obtainable by the method of the invention and the use thereof in a number of different applications.
Patent CA-2696063-A1 (CA)
Inventor: LEE DER-YANG
IPC: A61K31/19
Filed: 2007-08-15
Abstract: A method of administering non-steroidal-anti-inflammatory drugs, in particular propionic acid derivatives such as ibuprofen, is provided. The inventive dosage forms provide an initial release of the NSAID and a second sustained release of NSAID, preferably in a single dosing step.
Patent CA-2699859-A1 (CA)
Inventor: AGRIS PAUL F
IPC: C12Q1/68
Filed: 2008-09-12
Abstract: Methods of identifying inhibitors of retroviral propagation, tRNA used in the methods, and kits, including the tRNA, which can be used in the methods, are disclosed. Methods of treating or preventing retroviral infections by administering an effective amount of the inhibitors, and pharmaceutical compositions including the inhibitors, are also disclosed. The methods involve forming a mixture comprising a linear sequence of a tRNA anticodon stem loop fragment that is not capable of forming a stem-loop, a target nucleic acid molecule capable of binding to the tRNA anticodon stem loop fragment, and a test compound. The mixture is incubated under conditions that allow binding of the tRNA anticodon stem loop fragment and the target nucleic acid molecule in the absence of the test compound. Assays can then be performed that detect whether or not the test compound inhibits the binding of the tRNA anticodon stem loop fragment and the target nucleic acid molecule.
Patent CA-2704484-A1 (CA)
Inventor: VAN DER WOUDE JACOBUS HENDRICUS ANTONIUS
IPC: C03C25/26
Filed: 2008-11-10
Abstract: The present invention provides aqueous sizing compositions for application to glass fibers as well as polymeric resins reinforced with glass fibers at least partially coated with the aqueous sizing compositions. In some embodiments, sizing compositions of the present invention demonstrate advantageous properties resulting from the presence of an acid-amine component therein.
Patent CA-2715044-A1 (CA)
Title: Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
Inventor: ZURAWSKI GERARD
IPC: A61K39/395
Filed: 2008-02-01
Abstract: The present invention includes compositions and methods for increasing the effectiveness of antigen presentation using a DCIR-specific antibody or fragment thereof to which an antigen is attached that forms an antibody-antigen complex, wherein the antigen is processed and presented by a dendritic cell that has been contacted with the antibody-antigen complex.
Patent CA-2716239-A1 (CA)
Inventor: BEILENHOFF KAI
IPC: B65G17/32
Filed: 2009-02-19
Abstract: The invention is directed to a transport system (10) for blister packages (24) or the like, with a boom (12) for mounting on a vertical wall or the like. Guided in the boom is a finite chain (18) formed of hooks (22) such that it is slidable by hand out of a lower groove section via a turning point (43) into an upper groove section and vice versa, within guide grooves ex-tending along the two groove sections and the turning point. Blister packages or the like which are suspended from the hooks can be removed by hand only in the region of the turning point. A closed compartment is formed between each pair of neighboring hooks. It opens only in the region of the turning point for removal of a blister package or the like, so that only one blister package at a time can be removed from the chain.
Patent CA-2718911-A1 (CA)
Inventor: DUBAY RICKEY
IPC: G05B13/04
Filed: 2009-03-20
Abstract: A computer implemented method of conducting closed-loop control of a physical system comprising the steps of carrying out an initialization of the physical system to commencing closed-loop control, evaluating the optimal constrained control move using the system error and the initial normalized matrix using a control move solver; calculating a first control action by the sum of delta u(0) and the initial control action; and implementing the result to the physical system by converting the control action to an output control signal to effect a change in at least one operating variable.